The Fourth INTERMACS Annual Report: 4,000 implants and counting

The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of heart and lung transplantation 2012-02, Vol.31 (2), p.117-126
Hauptverfasser:	Kirklin, James K., MD, Naftel, David C., PhD, Kormos, Robert L., MD, Stevenson, Lynne W., MD, Pagani, Francis D., MD, PhD, Miller, Marissa A., DVM, MPH, Baldwin, J. Timothy, PhD, Young, James B., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	advanced heart failure Annual Reports as Topic Biological and medical sciences Cardiology. Vascular system destination therapy Female Heart Failure - mortality Heart Failure - surgery heart failure therapy Heart Transplantation - mortality Heart Transplantation - statistics & numerical data Heart-Assist Devices - utilization Humans Interinstitutional Relations INTERMACS Male mechanical circulatory support Medical sciences Middle Aged National Heart, Lung, and Blood Institute (U.S.) Registries - statistics & numerical data Risk Factors Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Survival Rate Treatment Outcome United States - epidemiology United States Food and Drug Administration ventricular assist devices
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adult primary implant population is provided, and the recent composition of patient profiles is examined. Current actuarial survival with continuous-flow pumps exceeds 80% at 1 year and 70% at 2 years.
ISSN:	1053-2498 1557-3117
DOI:	10.1016/j.healun.2011.12.001